Skip to main content

Want a detailed portfolio tracker?

ProMIS Neurosciences (PMN) P/E (2023 - 2026)

ProMIS Neurosciences (PMN) P/E from Oct 2, 2023 to Jul 21, 2026. The TTM ProMIS Neurosciences (PMN) P/E is -0.76. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of ProMIS Neurosciences (PMN)

YearP/EChange
2026-0.76+164.86%
2025-0.29-98.37%
2024-17.68+95.87%
2023-9.03N/A

Comparison ProMIS Neurosciences (PMN) P/E with competitors

ProMIS Neurosciences (PMN) P/E is -0.76.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.22%
NBYStablecoin Development Corp0.00-100.56%
ENLVEnlivex Ltd0.07-109.81%
FGENFibroGen Inc0.24-131.47%
CHRSCoherus Biosciences Inc0.85-211.23%
FBIOFortress Biotech Inc0.95-224.41%
ORMPOramed Pharmaceuticals Inc1.50-297.04%
AGENAgenus Inc3.01-494.53%
INVAInnoviva Inc3.15-513.46%
VXRTVaxart Inc3.55-565.33%
CRMDCorMedix Inc3.63-575.65%
CVACCureVac N.V.4.45-682.78%
GLPGGalapagos NV4.86-736.95%
SRPTSarepta Therapeutics Inc4.88-739.99%
ABEOAbeona Therapeutics Inc5.39-806.25%
ABUSArbutus Biopharma Corp5.60-833.53%
ZVRAZevra Therapeutics Inc5.89-871.75%
SPROSpero Therapeutics Inc6.23-916.48%
CGENCompugen Ltd6.31-927.69%
RIGLRigel Pharmaceuticals6.87-1000.86%
SLXNSilexion Therapeutics Corp7.30-1056.44%
OMEROmeros Corporation9.26-1313.73%
AUPHAurinia Pharmaceuticals Inc9.58-1356.49%
ACADAcadia Pharmaceuticals Inc11.73-1637.49%
TBPHTheravance Biopharma Inc12.26-1707.44%
ADMAAdma Biologics Inc12.42-1727.89%
HRMYHarmony Biosciences Holdings Inc13.82-1911.69%
SABSSAB Biotherapeutics Inc14.14-1953.11%
NAGENiagen Bioscience Inc14.82-2042.51%
INCYIncyte Corp15.82-2174.18%
REGNRegeneron Pharmaceuticals Inc15.86-2178.65%
PBYIPuma Biotechnology Inc17.32-2369.92%
CPRXCatalyst Pharmaceuticals Inc17.44-2386.12%
EXELExelixis Inc17.54-2399.06%
TGTXTG Therapeutics Inc18.97-2586.26%
MDXGMimedx Group Inc20.55-2794.23%
XOMAXOMA Royalty Corp22.87-3098.72%
ARGXArgen X SE24.30-3285.31%
CTMXCytomX Therapeutics Inc24.82-3353.89%
XOMAOXOMA Royalty Corp25.34-3422.54%
HALOHalozyme Therapeutics Inc25.62-3459.10%
XOMAPXOMA Royalty Corp25.67-3465.19%
VRTXVertex Pharmaceuticals Inc27.99-3769.93%
RPRXRoyalty Pharma plc - Class A28.69-3860.75%
SLNOSoleno Therapeutics Inc29.02-3903.72%
ASNDAscendis Pharma A/S30.09-4044.02%
LGNDLigand Pharmaceuticals Inc - Class B37.91-5070.02%
APLSApellis Pharmaceuticals Inc39.02-5215.43%
BMRNBiomarin Pharmaceutical Inc42.21-5633.70%
KRYSKrystal Biotech Inc45.34-6044.24%
ONCBeiGene Ltd69.54-9216.31%
PHARPharming Group N.V.75.03-9935.37%
TECHBio-Techne Corp101.96-13466.09%
VCELVericel Corp109.92-14509.99%
ALNYAlnylam Pharmaceuticals Inc117.96-15564.47%
GMABGenmab140.29-18491.22%
TLXTelix Pharmaceuticals Ltd162.15-21357.20%
CORTCorcept Therapeutics Inc212.86-28004.26%